Recombinant human lecithin:cholesterol acyltransferase Uses, Dosage, Side Effects and more
Recombinant human lecithin:cholesterol acyltransferase is under investigation in clinical trial NCT03578809 (A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction).
| Trade Name | Recombinant human lecithin:cholesterol acyltransferase |
| Generic | Recombinant human lecithin:cholesterol acyltransferase |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
